1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Human Microbiome Therapeutics Market: Focus on Drugs, Pipeline Analysis, Funding Scenario, Therapeutic Application, 10 Countries Data, and Competitive Landscape – Analysis and Forecast, 2019-2029

Global Human Microbiome Therapeutics Market: Focus on Drugs, Pipeline Analysis, Funding Scenario, Therapeutic Application, 10 Countries Data, and Competitive Landscape – Analysis and Forecast, 2019-2029

  • October 2019
  • 193 pages
  • ID: 5825701
  • Format: PDF
  • By BIS Research

Summary

Table of Contents

Global Human Microbiome Therapeutics Market to Grow at a CAGR of 33.00% from 2019-2029

Key Questions Answered in this Report:
• What are the key features of human microbiome therapeutics which makes them a better choice for the treatment of chronic and non-communicable disease?
• What is the industry structure of the human microbiome therapeutics market?
• How did the human microbiome therapeutics market evolve and what is its scope in the future?
• What are the key development strategies which are implemented by the key players to maintain and capture market share?
• What are the major market drivers, challenges, and opportunities in the global human microbiome therapeutics market?
• What are the current leading companies dominating the global human microbiome therapeutics market?
• What are the regulations pertaining to the global human microbiome therapeutics market?
• What are the initiatives implemented by different government bodies to reduce the incidence of disease and increase the adoption of human microbiome therapeutics product?
• What was the market value of the leading segments and sub-segments of the global human microbiome therapeutics market?
• How is each segment of the global human microbiome therapeutics market expected to grow during the forecast period and what is the revenue expected to be generated by each of the segments by the end of 2029?
• Which region carries the potential for the significant expansion of key companies for human microbiome therapeutics market?
• Which products are anticipated to be launched and generate revenue in the forecast period 2019-2029?

Global Human Microbiome Therapeutics Market Forecast, 2019-2029

Human Microbiome Therapeutics Industry Analysis projects the market to grow at a significant CAGR of 33.00% during the forecast period 2019-2029. The human microbiome therapeutics market generated $309.9 million revenue in 2018, in terms of value.

The human microbiome therapeutics growth has been primarily attributed to the major drivers in this market such as increasing prevalence and growing incidence of chronic diseases, growing investments and initiatives in the field of microbiome therapeutics, treatment options with minimal or no side effects, availability of private and government funding, and others.The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include product launches, and increasing merger and acquisitions among the industry players.

However, there are significant challenges which are restraining the market growth. These challenges include exorbitant cost is required for the clinical trials procedure and stringent regulatory guidelines for the product development and commercialization of the products.

Expert Quote

“With the elucidation of its causative role in cardiometabolic disease and atherosclerosis, the human gut microbiome holds promises as a reservoir of novel potential therapeutic targets as well as novel therapeutic agents, paving a new and exciting avenue in cardiovascular drug discovery and other areas.”

Scope of the Market Intelligence on Human Microbiome Therapeutics Market

The human microbiome therapeutics market research provides a holistic view of global market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products for different therapeutic applications in human microbiome therapeutics. In addition, the study also includes exhaustive information on expected commercial launches of the product in the forecast period, perception on the new product launches, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segments, and company, as well as other vital information with respect to global human microbiome therapeutics market.

Market Segmentation

The human microbiome therapeutics market is segmented into three categories, namely, product (by Phases), by disease, and by region.

The product segment includes the segmentation on the basis of different phases of clinical trials, and the disease segment includes, gastrointestinal and infectious diseases, oncology and autoimmune diseases, skin diseases, and neurological diseases.

The region segment is further segmented into North America, Europe, Asia-Pacific, and Rest-of-the-World.

Key Companies in the Global Human Microbiome Therapeutics Market

The key manufacturers who have been contributing significantly to the human microbiome therapeutics market include 4D Pharma plc, Immuron Limited, Sanofi SA., Seres Therapeutics Inc., Synthetic Biologics, Taisho Pharmaceutical, Ritter Pharmaceuticals, AOBiome, Finch Therapeutics, Rebiotix, Inc. (Subsidiary of Ferring Pharmaceutical), Maat Pharma, Ox Thera, Quorum Innovations, Vedanta Biosciences, Whole Biome, and Naked Biome among others.

Countries Covered
• North America
• U.S.
• Canada
• Europe
• France
• Sweden
• Germany
• U.K.
• Rest-of-Europe
• Asia-Pacific
• Japan
• Australia
• China
• India
• Rest-of-Asia-Pacific
• Rest-of-the-World
• Middle East and Africa
• Latin America

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off

($5000)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2020

Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2020

  • $ 2000
  • January 2020

Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2020SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2020, provides an ...

Interleukin 1 - Pipeline Review, H1 2020

Interleukin 1 - Pipeline Review, H1 2020

  • $ 3500
  • January 2020

Interleukin 1 - Pipeline Review, H1 2020SummaryInterleukin 1 (IL1) pipeline Target constitutes close to 24 molecules. Out of which approximately 23 molecules are developed by companies and remaining by ...

Anesthetic Effect - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

Anesthetic Effect - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020

"Anesthetic Effect - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Anesthetic Effect. The marketed ...


ref:plp2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on